Neutrophil gelatinase-associated lipocalin (NGAL) is a protein expressed by kidney tubular
cells in response to ischemia, but may also be an early indicator of immunological rejection …

The best option for the treatment of end-stage renal disease is kidney transplantation.
Prompt diagnosis and management of early posttransplantation complications is of utmost …

It is unclear if there is an association between the duration of delayed graft function (DGF)
and kidney transplant (KT) outcomes. This study investigated the impact of prolonged DGF …

Acute rejection is a major risk for renal transplant failure. During this adverse process,
activated T cells are considered the main effectors. Recently, B and T lymphocyte attenuator …

Introduction Delayed graft function (DGF) is a common condition that necessitates dialysis
during the first week after transplantation. Although DGF rarely occurs following living-donor …

With an increased incidence of living-donor kidney transplants, in response to increasing
unmet needs for renal transplant, a clear understanding of determinants of posttransplant …

Renal transplantation (RT) is considered the “gold standard” treatment for end-stage renal
disease patients. Efforts should be made to reduce ischaemia-reperfusion (IR) injury, which …

Materials and Methods. Patients transplanted between January 2011and February 2013
were randomly divided into 3 groups to receive routine anti-rejection medication only (n …

Kidney transplantation is the best option for end-stage chronic kidney disease. Transplant
viability is conditioned by drugs' nephrotoxicity, ischemia–reperfusion damage, or acute …

Objectives To determine the prevalence of hypoalbuminemia in children listed for renal
transplantation and to evaluate the effect of pretransplant hypoalbuminemia on …